Chronic Treatment with the γ-Secretase Inhibitor LY-411,575 Inhibits β-Amyloid Peptide Production and Alters Lymphopoiesis and Intestinal Cell DifferentiationGwendolyn T. Wong, Eric M. Parker, Hubert Josien et al.|Journal of Biological Chemistry|2004Cited by 716
MLi-2, a Potent, Selective, and Centrally Active Compound for Exploring the Therapeutic Potential and Safety of LRRK2 Kinase InhibitionMatthew Fell, John A. Morrow, Christian Mirescu et al.|Journal of Pharmacology and Experimental Therapeutics|2015Cited by 336